List of Tables
Table 1. Lung Disease Therapeutic Market Trends
Table 2. Lung Disease Therapeutic Market Drivers & Opportunity
Table 3. Lung Disease Therapeutic Market Challenges
Table 4. Lung Disease Therapeutic Market Restraints
Table 5. Global Lung Disease Therapeutic Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Lung Disease Therapeutic Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Lung Disease Therapeutic Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Lung Disease Therapeutic Product Type
Table 9. Key Companies Time to Begin Mass Production of Lung Disease Therapeutic
Table 10. Global Lung Disease Therapeutic Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutic as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Lung Disease Therapeutic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Lung Disease Therapeutic Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Lung Disease Therapeutic Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Lung Disease Therapeutic Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Lung Disease Therapeutic Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Lung Disease Therapeutic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Lung Disease Therapeutic Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Lung Disease Therapeutic Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Lung Disease Therapeutic Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Lung Disease Therapeutic Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Lung Disease Therapeutic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Lung Disease Therapeutic Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Lung Disease Therapeutic Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Lung Disease Therapeutic Sales Value by Region (2019-2024) & (%)
Table 27. Global Lung Disease Therapeutic Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Lung Disease Therapeutic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Lung Disease Therapeutic Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Lung Disease Therapeutic Sales Value, (2025-2030) & (US$ Million)
Table 31. GSK Basic Information List
Table 32. GSK Description and Business Overview
Table 33. GSK Lung Disease Therapeutic Products, Services and Solutions
Table 34. Revenue (US$ Million) in Lung Disease Therapeutic Business of GSK (2019-2024)
Table 35. GSK Recent Developments
Table 36. AstraZeneca Basic Information List
Table 37. AstraZeneca Description and Business Overview
Table 38. AstraZeneca Lung Disease Therapeutic Products, Services and Solutions
Table 39. Revenue (US$ Million) in Lung Disease Therapeutic Business of AstraZeneca (2019-2024)
Table 40. AstraZeneca Recent Developments
Table 41. Boehringer Ingelheim Basic Information List
Table 42. Boehringer Ingelheim Description and Business Overview
Table 43. Boehringer Ingelheim Lung Disease Therapeutic Products, Services and Solutions
Table 44. Revenue (US$ Million) in Lung Disease Therapeutic Business of Boehringer Ingelheim (2019-2024)
Table 45. Boehringer Ingelheim Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Lung Disease Therapeutic Products, Services and Solutions
Table 49. Revenue (US$ Million) in Lung Disease Therapeutic Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. Mylan Basic Information List
Table 52. Mylan Description and Business Overview
Table 53. Mylan Lung Disease Therapeutic Products, Services and Solutions
Table 54. Revenue (US$ Million) in Lung Disease Therapeutic Business of Mylan (2019-2024)
Table 55. Mylan Recent Developments
Table 56. Vertex Pharmaceuticals Basic Information List
Table 57. Vertex Pharmaceuticals Description and Business Overview
Table 58. Vertex Pharmaceuticals Lung Disease Therapeutic Products, Services and Solutions
Table 59. Revenue (US$ Million) in Lung Disease Therapeutic Business of Vertex Pharmaceuticals (2019-2024)
Table 60. Vertex Pharmaceuticals Recent Developments
Table 61. F. Hoffman La Roche Basic Information List
Table 62. F. Hoffman La Roche Description and Business Overview
Table 63. F. Hoffman La Roche Lung Disease Therapeutic Products, Services and Solutions
Table 64. Revenue (US$ Million) in Lung Disease Therapeutic Business of F. Hoffman La Roche (2019-2024)
Table 65. F. Hoffman La Roche Recent Developments
Table 66. Teva Pharmaceuticals Basic Information List
Table 67. Teva Pharmaceuticals Description and Business Overview
Table 68. Teva Pharmaceuticals Lung Disease Therapeutic Products, Services and Solutions
Table 69. Revenue (US$ Million) in Lung Disease Therapeutic Business of Teva Pharmaceuticals (2019-2024)
Table 70. Teva Pharmaceuticals Recent Developments
Table 71. Cipla Basic Information List
Table 72. Cipla Description and Business Overview
Table 73. Cipla Lung Disease Therapeutic Products, Services and Solutions
Table 74. Revenue (US$ Million) in Lung Disease Therapeutic Business of Cipla (2019-2024)
Table 75. Cipla Recent Developments
Table 76. Fibrogen Basic Information List
Table 77. Fibrogen Description and Business Overview
Table 78. Fibrogen Lung Disease Therapeutic Products, Services and Solutions
Table 79. Revenue (US$ Million) in Lung Disease Therapeutic Business of Fibrogen (2019-2024)
Table 80. Fibrogen Recent Developments
Table 81. Liminal Biosciences Basic Information List
Table 82. Liminal Biosciences Description and Business Overview
Table 83. Liminal Biosciences Lung Disease Therapeutic Products, Services and Solutions
Table 84. Revenue (US$ Million) in Lung Disease Therapeutic Business of Liminal Biosciences (2019-2024)
Table 85. Liminal Biosciences Recent Developments
Table 86. PharmAkea Therapeutics Basic Information List
Table 87. PharmAkea Therapeutics Description and Business Overview
Table 88. PharmAkea Therapeutics Lung Disease Therapeutic Products, Services and Solutions
Table 89. Revenue (US$ Million) in Lung Disease Therapeutic Business of PharmAkea Therapeutics (2019-2024)
Table 90. PharmAkea Therapeutics Recent Developments
Table 91. IQVIA Basic Information List
Table 92. IQVIA Description and Business Overview
Table 93. IQVIA Lung Disease Therapeutic Products, Services and Solutions
Table 94. Revenue (US$ Million) in Lung Disease Therapeutic Business of IQVIA (2019-2024)
Table 95. IQVIA Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Lung Disease Therapeutic Downstream Customers
Table 99. Lung Disease Therapeutic Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Lung Disease Therapeutic Product Picture
Figure 2. Global Lung Disease Therapeutic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Lung Disease Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 4. Lung Disease Therapeutic Report Years Considered
Figure 5. Global Lung Disease Therapeutic Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Disease Therapeutic Revenue in 2023
Figure 7. Lung Disease Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Asthma Picture
Figure 9. Chronic Obstructive Pulmonary Disease (COPD) Picture
Figure 10. Lung Cancer Picture
Figure 11. Other Picture
Figure 12. Global Lung Disease Therapeutic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Lung Disease Therapeutic Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital Pharmacies
Figure 15. Product Picture of Retail Pharmacies
Figure 16. Product Picture of Online Pharmacies
Figure 17. Global Lung Disease Therapeutic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Lung Disease Therapeutic Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Lung Disease Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Lung Disease Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Lung Disease Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Lung Disease Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Lung Disease Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Lung Disease Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Lung Disease Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Lung Disease Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Lung Disease Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Lung Disease Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Lung Disease Therapeutic Sales Value (%), (2019-2030)
Figure 30. United States Lung Disease Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Lung Disease Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Lung Disease Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Lung Disease Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Lung Disease Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Lung Disease Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 36. China Lung Disease Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Lung Disease Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 38. China Lung Disease Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Lung Disease Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Lung Disease Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Lung Disease Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Lung Disease Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Lung Disease Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Lung Disease Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Lung Disease Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Lung Disease Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Lung Disease Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 48. India Lung Disease Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Lung Disease Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 50. India Lung Disease Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 51. Lung Disease Therapeutic Industrial Chain
Figure 52. Lung Disease Therapeutic Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
